Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21671636rdf:typepubmed:Citationlld:pubmed
pubmed-article:21671636lifeskim:mentionsumls-concept:C0524465lld:lifeskim
pubmed-article:21671636lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:21671636lifeskim:mentionsumls-concept:C0444669lld:lifeskim
pubmed-article:21671636lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:21671636lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:21671636lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:21671636lifeskim:mentionsumls-concept:C0332514lld:lifeskim
pubmed-article:21671636lifeskim:mentionsumls-concept:C0294188lld:lifeskim
pubmed-article:21671636lifeskim:mentionsumls-concept:C0917735lld:lifeskim
pubmed-article:21671636pubmed:issue14lld:pubmed
pubmed-article:21671636pubmed:dateCreated2011-7-8lld:pubmed
pubmed-article:21671636pubmed:abstractTextRegio-, stereo-, and facial selective [4 + 2] cycloadditions between highly activated vinyl sulfones and 1,3-dienes derived from (R)-4-tert-butyldimethylsilyloxy-2-cyclohexen-1-one provide a powerful approach for the asymmetric synthesis of compounds containing the bicyclo[2.2.2]octanone carbon skeleton. This new methodology has been successfully applied to the asymmetric synthesis of the cis-decalin core structure of the potent anticancer marine natural products superstolides A and B.lld:pubmed
pubmed-article:21671636pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:languageenglld:pubmed
pubmed-article:21671636pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:citationSubsetIMlld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21671636pubmed:statusMEDLINElld:pubmed
pubmed-article:21671636pubmed:monthJullld:pubmed
pubmed-article:21671636pubmed:issn1523-7052lld:pubmed
pubmed-article:21671636pubmed:authorpubmed-author:HuaZhengmaoZlld:pubmed
pubmed-article:21671636pubmed:authorpubmed-author:JinZhendongZlld:pubmed
pubmed-article:21671636pubmed:authorpubmed-author:ChenLeiLlld:pubmed
pubmed-article:21671636pubmed:authorpubmed-author:LiGangqinGlld:pubmed
pubmed-article:21671636pubmed:copyrightInfo© 2011 American Chemical Societylld:pubmed
pubmed-article:21671636pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21671636pubmed:day15lld:pubmed
pubmed-article:21671636pubmed:volume13lld:pubmed
pubmed-article:21671636pubmed:ownerNLMlld:pubmed
pubmed-article:21671636pubmed:authorsCompleteYlld:pubmed
pubmed-article:21671636pubmed:pagination3580-3lld:pubmed
pubmed-article:21671636pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:meshHeadingpubmed-meshheading:21671636...lld:pubmed
pubmed-article:21671636pubmed:year2011lld:pubmed
pubmed-article:21671636pubmed:articleTitleControlling the facial selectivity of asymmetric [4+2] cyclo-additions: a concise synthesis of the cis-decalin core structure of superstolides A and B.lld:pubmed
pubmed-article:21671636pubmed:affiliationDivision of Medicinal and Natural Products Chemistry, Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, The University of Iowa, Iowa City, Iowa 52242, USAlld:pubmed
pubmed-article:21671636pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21671636pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed